Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had revenue of $74.27M in the quarter ending June 30, 2026, with 88.02% growth. This brings the company's revenue in the last twelve months to $239.66M, up 110.16% year-over-year. In the year 2025, Phathom Pharmaceuticals had annual revenue of $175.11M with 216.93% growth.

• Revenue (ttm): $239.66M
• Revenue Growth: +110.16%
• P/S Ratio: 2.32
• Revenue / Employee: $645,989
• Employees: 371
• Market Cap: 562.37M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	175.11M	119.86M	216.93%
Dec 31, 2024	55.25M	54.57M	8,001.47%
Dec 31, 2023	682.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 21, 2026

Data Sources Report a data error